Tesamorelin 20mg | Synthetic GHRH Analog Research Peptide

Tesamorelin | 20mg | Research Use Only

44 amino acids. One N-terminal modification. That's what makes Tesamorelin structurally different from native GHRH.

Tesamorelin is a synthetic peptide analog of human Growth Hormone-Releasing Hormone also called Growth Hormone-Releasing Factor (GRF) in older literature. The key structural difference is an N-terminal hexenoyl modification. In lab models, this modification is studied for its effect on peptide stability. Whether it changes binding behavior in any meaningful way is part of what researchers are still working out.

In scientific literature, Tesamorelin shows up as a GRF analog. Most research using it looks at growth hormone-related signaling under controlled experimental conditions. None of it is clinical. All preclinical.

This is a lab-only compound. Not for human use. Not for animals. Research only.

Scientific classification:

Common name: Tesamorelin
Salt form: Tesamorelin acetate (commonly referenced form)
Classification: Synthetic GRF analog
Peptide length: 44 amino acids
Structural feature: N-terminal hexenoyl modification

Chemical and structural info:

Molecular formula (free base): C221H366N72O67S
Molecular weight: ~5135.9 Da
Appearance: Sterile white to off-white lyophilized powder
Peptide type: Long-chain synthetic peptide

What researchers use it for:

Most lab work with Tesamorelin falls into a few categories. GHRH receptor interaction models are the most common. Growth hormone signaling pathway work in vitro is another. Peptide stability and structural modification research comes up a lot too, specifically because of that hexenoyl group. Endocrine pathway receptor-binding studies and SAR analysis of GRF analogs round it out.

All of the above is strictly lab and investigational research. No medical claims. No therapeutic claims.

Researchers working on dual-peptide endocrine signaling may also find our Ipamorelin 10mg research peptide combination relevant it covers complementary GHRH and GHS receptor pathway work.

Product details:

Category: Synthetic research peptide
Form: Sterile lyophilized powder
Quantity: 20mg per unit
Intended use: Laboratory and developmental research only

Regulatory status:

Not FDA approved. This compound is not for diagnosing, treating, curing, or preventing any disease. Statements here have not been evaluated by the FDA. Sold for lab research only nothing else.

Not a supplement. Not a pharmaceutical. Check the terms before ordering.

Safety:

Handle with proper lab equipment. Training is required. Long-term safety data on this compound is limited standard for investigational peptides. Do not consume it. Keep away from children. By purchasing, you accept responsibility for safe handling and agree to our indemnification terms.